Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Healthcare — Equipment & Devices.”
₹38 Cr revenue.
COGS 68.4%, employees 7.7%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 13.9%▲ | 12.3% |
| ROCE | 18.3%▲ | 15.3% |
| Net Margin | 8.4%▼ | 8.5% |
| EBITDA Margin | 13.7%▼ | 14.9% |
| Debt To Equity | 0.11x▲ | 0.10x |
Historical valuation data not available.
Revenue segment breakdown not available.
| (₹ Cr) | FY2025 | FY2024 |
|---|---|---|
| Revenue | ₹38 Cr +23.6% | ₹31 Cr |
| Other Income | ₹1 Cr +5.5% | ₹1 Cr |
| Total Income | ₹40 Cr +22.9% | ₹32 Cr |
| COGS | ₹26 Cr +18.6% | ₹22 Cr |
| ₹35 Cr +22.9% | ₹29 Cr | |
| Profit Before Tax | ₹4 Cr +22.8% | ₹4 Cr |
| ₹0.96 Cr +10.1% | ₹0.87 Cr | |
| Net Profit | ₹3 Cr +26.9% | ₹3 Cr |
| EPS | ₹3.86 | ₹3.04 |
| Diluted Shares | ₹0.87 Cr | ₹0.87 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Amkay Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Audited Financial Results of .... Amkay Pro...
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td>...
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</...
Reply to clarification on Price movement sought by BSE Limited
The Exchange has sought clarification from Amkay Products Ltd on December 11, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant .... The Exch...
Unaudited Financial Result for the half year ended September 30, 2025
Outcome of the Board Meeting held on Wednesday, 12th November, 2025 for consider and approve the unaudited financial result for the half year ended September 30, 2025
Amkay Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the unaudited financial result .... Amkay P...
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2015
Scrutisiner Report and Voting Result for AGM
Proceedings of the 18th Annual General Meeting
Intimation for Closure of Trading window for decalration of financial result for the half year ended 30th September, 2025
Newspaper Pubication for the purpose of AGM Notice
Intimation of Book closure
Annaul Report for FY 2024-25 as per Reg. 34 of SEBI LODR, 2015.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
No dividend history available for this company.